Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Gili Halfteck

Concepts (60)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
3
2024
1212
0.660
Why?
Gallbladder Neoplasms
1
2019
7
0.630
Why?
Adenoma
1
2019
113
0.560
Why?
Adenocarcinoma
1
2019
405
0.470
Why?
Neoplasm Invasiveness
2
2024
278
0.360
Why?
Natural Cytotoxicity Triggering Receptor 1
1
2009
5
0.310
Why?
Antigens, Ly
1
2009
12
0.310
Why?
Cytotoxicity, Immunologic
1
2009
58
0.310
Why?
Killer Cells, Natural
1
2009
116
0.290
Why?
Lymphoma
1
2009
71
0.290
Why?
Laparoscopy
2
2022
180
0.260
Why?
Mastectomy
2
2023
143
0.240
Why?
Retrospective Studies
6
2024
6607
0.240
Why?
Parathyroid Neoplasms
1
2024
27
0.220
Why?
Axilla
1
2024
92
0.220
Why?
Neoplasm Staging
2
2024
772
0.220
Why?
Neoplasm Recurrence, Local
3
2024
649
0.220
Why?
Sentinel Lymph Node Biopsy
1
2024
120
0.210
Why?
Radiotherapy, Adjuvant
1
2023
63
0.210
Why?
Lymph Node Excision
1
2024
133
0.210
Why?
Neoadjuvant Therapy
1
2024
125
0.210
Why?
Intestinal Fistula
1
2022
9
0.190
Why?
Mammaplasty
1
2022
43
0.190
Why?
Lymph Nodes
1
2023
258
0.180
Why?
Crohn Disease
1
2022
117
0.170
Why?
Prospective Studies
1
2023
2481
0.140
Why?
Infant, Newborn
1
2023
2867
0.120
Why?
Cushing Syndrome
1
2014
9
0.120
Why?
Adrenalectomy
1
2014
31
0.120
Why?
Adrenal Glands
1
2014
39
0.120
Why?
Pheochromocytoma
1
2014
35
0.110
Why?
Adrenal Gland Neoplasms
1
2014
49
0.110
Why?
Female
6
2024
28171
0.110
Why?
Humans
7
2024
52483
0.100
Why?
Postoperative Complications
2
2022
1068
0.100
Why?
Survival Rate
2
2024
945
0.090
Why?
Follow-Up Studies
2
2024
2279
0.080
Why?
Flow Cytometry
1
2009
478
0.060
Why?
Mice, Knockout
1
2009
879
0.060
Why?
Parathyroidectomy
1
2024
46
0.060
Why?
Chemotherapy, Adjuvant
1
2024
124
0.060
Why?
Lymphatic Metastasis
1
2024
220
0.050
Why?
Adult
3
2024
14161
0.050
Why?
Middle Aged
3
2024
13028
0.050
Why?
Ileum
1
2022
88
0.050
Why?
Colon
1
2022
104
0.050
Why?
Insurance Coverage
1
2022
115
0.040
Why?
Aged
2
2024
10121
0.040
Why?
Prognosis
1
2024
2099
0.040
Why?
Prevalence
1
2022
1006
0.040
Why?
Mice
1
2009
5949
0.040
Why?
Treatment Outcome
2
2022
5422
0.040
Why?
Healthcare Disparities
1
2022
299
0.040
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2024
1031
0.040
Why?
Male
3
2024
26761
0.030
Why?
Israel
1
2014
10
0.030
Why?
Comparative Effectiveness Research
1
2014
47
0.030
Why?
Neoplasm Metastasis
1
2014
243
0.030
Why?
Animals
1
2009
13505
0.030
Why?
Reproducibility of Results
1
2014
1229
0.020
Why?
Halfteck's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Similar People Expand Description
_